Improved bioprinted tumor organoids help predict treatment response
“The team [at UCLA’s Johnson Comprehensive Cancer Center] combined their bioprinted cells with [MORE]
HSLCI Melanoma Cell
A group of scientists from VCU Massey Cancer Center and UCLA Jonsson Comprehensive Cancer Center have developed a [MORE]
Angle-resolved low coherence interferometry (a/LCI) is a technology that allows oncologists to determine how effectively an anticancer drug is working. [MORE]